retatrutide korea approval Eli Lilly's next-generation obesity treatment "retatrutide" has ignited competition for next-generat retatrutide clinical trial south korea

dulaglutide, NEJM, 2025 Semaglutide and cartilage regeneration Cell Metabolism, 2026 Lean mass loss with GLP-1 drugs systematic review, 2024 Retatrutide Phase 2 NEJM, 2023 Myostatin gene discovery McPherron et al., Nature, 1997 German myostatin-knockout child Schuelke et al., NEJM, 2004 Myostatin inhibitor history Nielsen et al., Cells, 2021 Micronutrient joint advisory Mozaffarian et al., 2025 Last Updated on June 20, 2026 by Joe Garma

Obvious neurological and/or cardiovascular symptoms may represent a culmination of gastrointestinal beriberi, probably triggered by challenges that increase metabolic demands or decrease intracellular transport of thiamin, such as stress, infection, trauma, drug administration

It goes to work while you sleep, visibly firming, smoothing, and deeply hydrating skin

Your Next Step Toward Healthier Gums and a Confident Smile GLP-1 and oral health are closely linked

Cell, 149 (1), 2235